- Drugmaker Bayer leads One Drop’s $40M Series B funding round and enters commercial agreement to license One Drop's digital diabetes management platform in its global bio-digital efforts in therapeutic areas. - Bayer will leverage One Drop's data science and predictive capabilities, and harness its mobile platform to deliver innovative bio-digital solutions across a broad array of therapeutic areas.- One Drop provides personalized health programs to drive sustainable behavior change as part of
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
Life Image Launches Real World Imaging for RWE Programs
- Life Image launches Real World Imaging (RWI) offering to respond to researcher needs for maturing insights and accelerating drug development decisions.
- Imaging data, especially for Real World Evidence (RWE), has historically been difficult, if not impossible, to access, retrieve, view, de-identify and normalize at-scale, even though it provides clinically material insights for a growing number of therapies.
- Life Image represents the only company providing large, heterogeneous,
Read More
Report: Precision Medicine Is Impossible Without AI and Machine Learning
Artificial intelligence (AI) and machine learning are driving a great deal of the healthcare innovation in precision medicine, according to a new Chilmark Research report. The report reveals achieving the full potential of precision medicine is impossible to realize without applying AI and machine learning. Specifically, leveraging advanced machine learning and deep learning technology can rapidly analyze large datasets that outperform clinicians and researchers. Precision Medicine: Making
Read More
FDA Cancer OCE, Syapse Partner on Regulatory Use of Real-World Evidence (RWE)
Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement (RCA) focused on the use of real-world evidence (RWE) to support regulatory decision-making. Syapse and the OCE will work with stakeholders across the FDA to address key regulatory questions about testing and treatment patterns, dosing and safety, and outcomes in oncology, with a focus on precision medicine.Methods to Derive RWE From Multiple
Read More
Mercy Launches a Nationwide Real-World Evidence (RWE) Network to Pool De-Identified Patient Data
Mercy Technology Services (MTS), the information technology arm of St. Louis-based Mercy health system, has launched a nationwide real-world evidence network to pool clinical data for advanced analysis. The new initiative aims to create a new model of curated data sharing among providers, drug and device makers, regulators and more to power better patient care.MTS Real-World Evidence (RWE) Network BackgroundDeveloped in partnership with global tech giant SAP, MTS’ new network aims to tap into
Read More
What’s AI’s Holdup in Healthcare? The Answer Is In The Cloud
When you consider what technology has the most potential to transform healthcare over the next decade and beyond, no doubt your first thoughts turn to artificial intelligence (AI), machine learning (ML) and deep learning (DL). Already these technologies are showing promise in helping clinicians work faster and smarter, identifying trends, alerting us to signs that can predict and prevent diseases, and providing insights into potential treatments and cures.
But AI, ML, and DL alone cannot
Read More
Nordic Expands Beyond Epic With New Cerner Solutions Business Line
Healthcare IT consulting firm Nordic continues its expansion beyond Epic consulting with the launch of a new Cerner Solutions business line to meet the needs of healthcare organizations. The new business line reflects Nordic’s long-term strategy of expanding its offerings beyond Epic consulting to meet the needs of its clients, including advisory services, performance improvement, ERP Solutions, and Managed Services. Nordic acquired The Claro Group's revenue cycle management (RCM) transformation
Read More
SHUH, Syapse to Build South Korea’s First Real-World Data Sharing Network for Precision Oncology Hospitals
SNUH and Syapse will collaboratively work towards building South Korea’s first real-world data-sharing network for leading precision oncology hospitals in the region. Syapse, a company accelerating precision medicine through insights derived from its global health system network, and Seoul National University Hospital (SNUH), a South Korea-based hospital, today announced that they have extended their partnership with a new multi-year agreement. As part of their partnership, SNUH and Syapse will
Read More
Research: July Digital Health IPOs, M&A Activity, Public Company Performance Summary
Summary of Health IT/digital IPOs, merger & acquisition (M&A) activity, and public company performance during the month of July.
Digital Health IPOs in July
Breaking the digital health IPO drought, there were four initial public offerings (IPOs) during a five-week period from late June to late July, including Livongo, Health Catalyst, Phreesia, and Change Healthcare. The last health IT companies to reach IPO were iRhythym Technologies and Tabula Rasa Healthcare in late 2016 -
Read More
Pfizer, Syapse Partner on Oncology Precision Medicine Using Real-World Evidence (RWE)
Syapse, a San Francisco, CA-based precision medicine company, today announced that it has entered into a strategic collaboration with Pfizer to advance cancer outcomes research using real-world evidence (RWE) toward the ultimate goal of improving patient health. This collaboration will initially focus on the molecular testing and therapy choices on precision oncology journeys in the healthcare system setting.Syapse NetworkThe Syapse Network enables health systems and their providers to learn
Read More
